MIRM
Price
$49.63
Change
+$0.61 (+1.24%)
Updated
Jun 13 closing price
Capitalization
2.46B
47 days until earnings call
PVCT
Price
$0.07
Change
-$0.01 (-12.50%)
Updated
Jun 13 closing price
Capitalization
30.97M
Interact to see
Advertisement

MIRM vs PVCT

Header iconMIRM vs PVCT Comparison
Open Charts MIRM vs PVCTBanner chart's image
Mirum Pharmaceuticals
Price$49.63
Change+$0.61 (+1.24%)
Volume$442.13K
Capitalization2.46B
Provectus Biopharmaceuticals
Price$0.07
Change-$0.01 (-12.50%)
Volume$186.54K
Capitalization30.97M
MIRM vs PVCT Comparison Chart
Loading...
MIRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MIRM vs. PVCT commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MIRM is a StrongBuy and PVCT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2025
Stock price -- (MIRM: $49.63 vs. PVCT: $0.07)
Brand notoriety: MIRM and PVCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MIRM: 108% vs. PVCT: 120%
Market capitalization -- MIRM: $2.46B vs. PVCT: $30.97M
MIRM [@Biotechnology] is valued at $2.46B. PVCT’s [@Biotechnology] market capitalization is $30.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MIRM’s FA Score shows that 1 FA rating(s) are green whilePVCT’s FA Score has 1 green FA rating(s).

  • MIRM’s FA Score: 1 green, 4 red.
  • PVCT’s FA Score: 1 green, 4 red.
According to our system of comparison, MIRM is a better buy in the long-term than PVCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MIRM’s TA Score shows that 6 TA indicator(s) are bullish while PVCT’s TA Score has 2 bullish TA indicator(s).

  • MIRM’s TA Score: 6 bullish, 5 bearish.
  • PVCT’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, MIRM is a better buy in the short-term than PVCT.

Price Growth

MIRM (@Biotechnology) experienced а +7.01% price change this week, while PVCT (@Biotechnology) price change was -1.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.63%. For the same industry, the average monthly price growth was +13.05%, and the average quarterly price growth was +4.06%.

Reported Earning Dates

MIRM is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (-0.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MIRM($2.46B) has a higher market cap than PVCT($31M). MIRM YTD gains are higher at: 20.024 vs. PVCT (-38.651). PVCT has higher annual earnings (EBITDA): -5.17M vs. MIRM (-37.56M). MIRM has more cash in the bank: 278M vs. PVCT (390K). PVCT has less debt than MIRM: PVCT (2.58M) vs MIRM (317M). MIRM has higher revenues than PVCT: MIRM (379M) vs PVCT (0).
MIRMPVCTMIRM / PVCT
Capitalization2.46B31M7,929%
EBITDA-37.56M-5.17M727%
Gain YTD20.024-38.651-52%
P/E RatioN/AN/A-
Revenue379M0-
Total Cash278M390K71,282%
Total Debt317M2.58M12,301%
FUNDAMENTALS RATINGS
MIRM vs PVCT: Fundamental Ratings
MIRM
PVCT
OUTLOOK RATING
1..100
182
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
4
Undervalued
PROFIT vs RISK RATING
1..100
1480
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
4190
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PVCT's Valuation (4) in the null industry is somewhat better than the same rating for MIRM (65). This means that PVCT’s stock grew somewhat faster than MIRM’s over the last 12 months.

MIRM's Profit vs Risk Rating (14) in the null industry is significantly better than the same rating for PVCT (80). This means that MIRM’s stock grew significantly faster than PVCT’s over the last 12 months.

MIRM's SMR Rating (96) in the null industry is in the same range as PVCT (100). This means that MIRM’s stock grew similarly to PVCT’s over the last 12 months.

MIRM's Price Growth Rating (41) in the null industry is somewhat better than the same rating for PVCT (90). This means that MIRM’s stock grew somewhat faster than PVCT’s over the last 12 months.

MIRM's P/E Growth Rating (100) in the null industry is in the same range as PVCT (100). This means that MIRM’s stock grew similarly to PVCT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MIRMPVCT
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 5 days ago
76%
Declines
ODDS (%)
Bearish Trend 18 days ago
69%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
75%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MIRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NSFDX8.85-0.05
-0.56%
Natixis Target Retirement 2020 N
JDVCX15.77-0.14
-0.88%
JPMorgan Diversified C
NQGCX38.39-0.40
-1.03%
Nuveen Global Equity Income C
GSCGX32.89-0.43
-1.29%
Goldman Sachs Large Cap Equity A
WMGYX26.54-0.54
-1.99%
Macquarie Mid Cap Growth Y

MIRM and

Correlation & Price change

A.I.dvisor indicates that over the last year, MIRM has been loosely correlated with SLRX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MIRM jumps, then SLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIRM
1D Price
Change %
MIRM100%
+1.24%
SLRX - MIRM
41%
Loosely correlated
-7.03%
RARE - MIRM
41%
Loosely correlated
-4.58%
CRNX - MIRM
39%
Loosely correlated
-1.24%
IMVT - MIRM
37%
Loosely correlated
-1.76%
FHTX - MIRM
37%
Loosely correlated
-4.85%
More

PVCT and

Correlation & Price change

A.I.dvisor tells us that PVCT and SPRC have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PVCT and SPRC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PVCT
1D Price
Change %
PVCT100%
-3.43%
SPRC - PVCT
25%
Poorly correlated
-1.05%
XTLB - PVCT
23%
Poorly correlated
-6.67%
MIRM - PVCT
23%
Poorly correlated
+1.24%
CCCC - PVCT
23%
Poorly correlated
+3.70%
AGEN - PVCT
23%
Poorly correlated
-2.49%
More